These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36530328)

  • 41. HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63‑mediated tight junction molecules and p21‑mediated growth arrest.
    Kakiuchi A; Kakuki T; Ohwada K; Kurose M; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Himi T; Takano KI; Kojima T
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
    Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
    Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk
    Tanaka N; Patel AA; Tang L; Silver NL; Lindemann A; Takahashi H; Jaksik R; Rao X; Kalu NN; Chen TC; Wang J; Frederick MJ; Johnson F; Gleber-Netto FO; Fu S; Kimmel M; Wang J; Hittelman WN; Pickering CR; Myers JN; Osman AA
    Clin Cancer Res; 2017 Nov; 23(21):6541-6554. PubMed ID: 28790110
    [No Abstract]   [Full Text] [Related]  

  • 44. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines.
    Chang HW; Lee YS; Nam HY; Han MW; Kim HJ; Moon SY; Jeon H; Park JJ; Carey TE; Chang SE; Kim SW; Kim SY
    Cell Signal; 2013 Apr; 25(4):839-47. PubMed ID: 23280187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Bcl-2 potentiates AZD-2014-induced anti-head and neck squamous cell carcinoma cell activity.
    Li Y; Cui JT
    Biochem Biophys Res Commun; 2016 Sep; 477(4):607-613. PubMed ID: 27343560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma:
    Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R
    Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy.
    Chang I; Wang CY
    J Biol Chem; 2016 Aug; 291(35):18199-209. PubMed ID: 27369083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eating Green: Shining Light on the Use of Dietary Phytochemicals as a Modern Approach in the Prevention and Treatment of Head and Neck Cancers.
    Eastham LL; Howard CM; Balachandran P; Pasco DS; Claudio PP
    Curr Top Med Chem; 2018; 18(3):182-191. PubMed ID: 29332583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells.
    Rodrigues-Junior DM; de Almeida Pontes NM; de Albuquerque GE; Carlin V; Perecim GP; Raminelli C; Vettore AL
    Invest New Drugs; 2020 Feb; 38(1):70-78. PubMed ID: 31102120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
    Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
    Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.
    Tripathi P; Kamarajan P; Somashekar BS; MacKinnon N; Chinnaiyan AM; Kapila YL; Rajendiran TM; Ramamoorthy A
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1852-61. PubMed ID: 22743333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
    Hou W; Fan Q; Su L; Xu H
    Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma.
    Vo-Hoang Y; Paiva S; He L; Estaran S; Teng Y
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
    He L; Gao L; Shay C; Lang L; Lv F; Teng Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):84. PubMed ID: 30777099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1.
    Potala S; Verma RS
    Mol Biol Rep; 2011 Feb; 38(2):1389-97. PubMed ID: 20814829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel CREB5/TOP1MT axis confers cisplatin resistance through inhibiting mitochondrial apoptosis in head and neck squamous cell carcinoma.
    Tong T; Qin X; Jiang Y; Guo H; Wang X; Li Y; Xie F; Lu H; Zhai P; Ma H; Zhang J
    BMC Med; 2022 Jul; 20(1):231. PubMed ID: 35773668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma.
    Wu Y; Wang Y; Diao P; Zhang W; Li J; Ge H; Song Y; Li Z; Wang D; Liu L; Jiang H; Cheng J
    Theranostics; 2019; 9(6):1777-1793. PubMed ID: 31037138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.